Search research articles
Contact Us
Filters
Showing results (71-80 of 189) with videos related to
Page
of 19
Sort By:
Journal of Biological Response Modifiers
|
December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma
T Hercend, F Farace, D Baume, et al.
Bulletin Du Cancer
|
February 15, 2001
[Reliability of the response rate in oncology: analysis of the causes for variation]
S Négrier, L Ollivier, D Di Stefano-Louineau, et al.
Blood
|
April 26, 2000
Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas
N Guerra, M Guillard, E Angevin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
Y Loriot, C Massard, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
G Batist, F Patenaude, P Champagne, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
July 1, 1994
T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapy
E Savelieva, F Farace, E Angevin, et al.
European Cytokine Network
|
June 9, 2005
The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves Bax
S Wittnebel, A Jalil, J Thiery, et al.
International Journal of Cancer
|
June 11, 1997
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines
F Farace, E Angevin, I Poullion, et al.
Intensive Care Medicine
|
January 1, 1991
Wegener's granulomatosis presenting as diffuse pulmonary hemorrhage
B Misset, D Glotz, B Escudier, et al.
Annales De Dermatologie Et De Venereologie
|
October 22, 2008
[Eruptive nevi associated with sorafenib treatment]
M Bennani-Lahlou, C Mateus, B Escudier, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 189) with videos related to
Sort By:
Page
of 19
Journal of Biological Response Modifiers
|
December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma
T Hercend, F Farace, D Baume, et al.
Bulletin Du Cancer
|
February 15, 2001
[Reliability of the response rate in oncology: analysis of the causes for variation]
S Négrier, L Ollivier, D Di Stefano-Louineau, et al.
Blood
|
April 26, 2000
Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas
N Guerra, M Guillard, E Angevin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features
Y Loriot, C Massard, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels
G Batist, F Patenaude, P Champagne, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
July 1, 1994
T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapy
E Savelieva, F Farace, E Angevin, et al.
European Cytokine Network
|
June 9, 2005
The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves Bax
S Wittnebel, A Jalil, J Thiery, et al.
International Journal of Cancer
|
June 11, 1997
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines
F Farace, E Angevin, I Poullion, et al.
Intensive Care Medicine
|
January 1, 1991
Wegener's granulomatosis presenting as diffuse pulmonary hemorrhage
B Misset, D Glotz, B Escudier, et al.
Annales De Dermatologie Et De Venereologie
|
October 22, 2008
[Eruptive nevi associated with sorafenib treatment]
M Bennani-Lahlou, C Mateus, B Escudier, et al.
Page
of 19